|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06160 BEONE MEDICINES
Nominal 
180.600 -4.400 (-2.378%) Ranking Overview
Ranking based on 16 research report(s)
Average Ranking 1.94
|
Strong Buy (1)
1
|
Buy (2)
15
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 20.00 USD (cts) | |
| Net Profit | 286.93 USD (MIL) | DPS | 0.00 USD (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (USD (MIL)) |
EPS/ ((LPS)(USD (cts)) |
DPS (USD (cts)) |
Net Asset Value per Share (USD) |
Highest (USD (MIL)) |
Lowest (USD (MIL)) |
| 2026 | 624.00 | 45.04 | 0 | -- | 918.90 | 558.00 |
| 2027 | 1,046.05 | 77.33 | 0 | -- | 2,224.00 | 875.00 |
| 2028 | 1,768.30 | 150.38 | 0 | -- | 2,276.00 | 1,416.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (USD (MIL)) |
EPS*/ (LPS) (USD (cts)) |
DPS * (USD (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 640.10 | 44.66 | -- | DBS | Buy | 290.00 | 06/02/2026 | |
| 2026 | 847.00 | 58.92 | -- | CLSA | OutPerform | 288.00 | 07/11/2025 | |
| 2026 | 749.00 | 54.15 | -- | UBS | Buy | 270.60 | 27/02/2026 | |
| 2026 | 570.00 | 42.58 | -- | NOMURA | Buy | 263.69 | 12/02/2026 | |
| 2026 | 631.00 | 45.00 | -- | CITIGROUP | Buy | 258.00 | 27/02/2026 | |
| 2026 | 586.70 | 87.20 | -- | UOB | Buy | 252.00 | 27/02/2026 | |
| 2026 | 617.00 | 45.08 | -- | BANK OF AMERICA | Buy | 243.83 | 27/02/2026 | |
| 2026 | 791.00 | 56.10 | -- | DAIWA | Buy | 240.00 | 01/12/2025 | |
| 2026 | 609.30 | 43.50 | -- | MACQUARIE | OutPerform | 236.00 | 09/12/2025 | |
| 2026 | 918.90 | 63.85 | -- | CMB INT'L SEC | Buy | 235.46 | 10/11/2025 | |
| 2026 | 575.00 | 38.08 | -- | MORGAN STANLEY | Overweight | 234.00 | 06/11/2025 | |
| 2026 | 558.00 | 36.20 | -- | CCBI | OutPerform | 234.00 | 10/11/2025 | |
| 2026 | 882.00 | 65.00 | -- | BOCOM | Buy | 231.00 | 10/11/2025 | |
| 2026 | 602.00 | 42.00 | -- | HSBC | Buy | 222.00 | 27/10/2025 | |
| 2026 | 755.34 | 48.96 | -- | CITIC SEC | Buy | 218.00 | 01/01/2026 | |
| 2026 | 611.00 | 40.00 | 40.00 | HAITONG | OutPerform | 212.09 | 01/03/2026 | |
| 2027 | 975.60 | 68.08 | -- | DBS | -- | -- | 06/02/2026 | |
| 2027 | 1,266.00 | 88.08 | -- | CLSA | -- | -- | 07/11/2025 | |
| 2027 | 1,401.00 | 101.23 | -- | UBS | -- | -- | 27/02/2026 | |
| 2027 | 1,049.00 | 78.40 | -- | NOMURA | -- | -- | 12/02/2026 | |
| 2027 | 1,026.00 | 74.00 | -- | CITIGROUP | -- | -- | 27/02/2026 | |
| 2027 | 1,043.10 | 120.50 | -- | UOB | -- | -- | 27/02/2026 | |
| 2027 | 1,387.00 | 101.31 | -- | BANK OF AMERICA | -- | -- | 27/02/2026 | |
| 2027 | 985.00 | 69.90 | -- | DAIWA | -- | -- | 01/12/2025 | |
| 2027 | 999.00 | 71.40 | -- | MACQUARIE | -- | -- | 09/12/2025 | |
| 2027 | 1,345.70 | 93.54 | -- | CMB INT'L SEC | -- | -- | 10/11/2025 | |
| 2027 | 1,017.00 | 67.46 | -- | MORGAN STANLEY | -- | -- | 06/11/2025 | |
| 2027 | 2,224.00 | 144.30 | -- | CCBI | -- | -- | 10/11/2025 | |
| 2027 | 1,554.00 | 114.00 | -- | BOCOM | -- | -- | 10/11/2025 | |
| 2027 | 875.00 | 61.00 | -- | HSBC | -- | -- | 27/10/2025 | |
| 2027 | 1,175.76 | 76.26 | -- | CITIC SEC | -- | -- | 01/01/2026 | |
| 2027 | 1,040.00 | 70.00 | 70.00 | HAITONG | -- | -- | 01/03/2026 | |
| 2028 | 2,276.00 | 164.38 | -- | UBS | -- | -- | 27/02/2026 | |
| 2028 | 1,416.00 | 102.00 | -- | CITIGROUP | -- | -- | 27/02/2026 | |
| 2028 | 1,669.60 | 165.40 | -- | UOB | -- | -- | 27/02/2026 | |
| 2028 | 1,867.00 | 136.38 | -- | BANK OF AMERICA | -- | -- | 27/02/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 03/03/2026 11:26 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD 286,933 |
| %Change | -- |
| EPS / (LPS) | USD 0.200 |
| NBV Per Share ($) | USD 2.831 |